Aprotinin attenuated ischemia–reperfusion injury in an isolated rat lung model after 18-hours preservation
Author(s) -
Takehiko Shimoyama,
Noriyuki Tabuchi,
Katsuo Kojima,
Hideki Akamatsu,
Hirokuni Arai,
Hiroyuki Tanaka,
Makoto Sunamori
Publication year - 2005
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1016/j.ejcts.2005.06.038
Subject(s) - aprotinin , reperfusion injury , lung , medicine , ischemia , anesthesia , lung transplantation , ulinastatin , edema , extravasation , pharmacology , immunology
Ischemia-reperfusion injury is a major factor in the early phase of lung transplantation. We hypothesized that aprotinin, a nonspecific serine protease inhibitor, attenuates ischemia-reperfusion lung injury by inhibiting the inflammatory response and suppressing NADPH oxidase.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom